C-type natriuretic peptide and its receptors in atherosclerotic plaques of the carotid artery of clinically asymptomatic patients

European Journal of Vascular and Endovascular Surgery

Volumn 43, Issue 6, 2012, Pages 649-654

  Kuehnl, A ^a   Pelisek, J ^a   Pongratz, J ^a   Eckstein, H H ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Arteriosclerosis; C type natriuretic peptide; Carotid artery plaques; Natriuretic peptide receptors; Plaque vulnerability

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MESSENGER RNA; NATRIURETIC PEPTIDE RECEPTOR 2; NATRIURETIC PEPTIDE RECEPTOR 3; NATRIURETIC PEPTIDE TYPE C; NITRATE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CAROTID ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; ASYMPTOMATIC DISEASES; BIOLOGICAL MARKERS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; FEMALE; GENE EXPRESSION REGULATION; GERMANY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, C-TYPE; PLAQUE, ATHEROSCLEROTIC; PROGNOSIS; RECEPTORS, ATRIAL NATRIURETIC FACTOR; RETROSPECTIVE STUDIES;

EID: 84861187784     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2012.02.010     Document Type: Article

References (32)

1. H.H. Eckstein Surgical therapy of extracranial carotid stenosis Chirurg 75 2004 93 110
2. C.D. Liapis, P.R. Bell, D. Mikhailidis, J. Sivenius, A. Nicolaides, and E. Fernandes ESVS guidelines. Invasive treatment for carotid stenosis: indications, techniques Eur J Vasc Endovasc Surg 37 2009 1 19
3. B.R. Chambers, and G.A. Donnan Carotid endarterectomy for asymptomatic carotid stenosis Cochrane Database Syst Rev 2005 CD001923
4. Libby P, Okamoto Y, Rocha VZ, Folco E. Inflammation in atherosclerosis: transition from theory to practice. Circ J;74:213-220.
5. F. Trostdorf, M. Buchkremer, A. Harmjanz, M. Kablau, S. Jander, and K. Geiger Fibrous cap thickness and smooth muscle cell apoptosis in high-grade carotid artery stenosis Eur J Vasc Endovasc Surg 29 2005 528 535
6. J. Pelisek, M. Rudelius, P. Zepper, H. Poppert, C. Reeps, and T. Schuster Multiple biological predictors for vulnerable carotid lesions Cerebrovasc Dis 28 2009 601 610
7. M. Sitzer, and F. Trostdorf The unstable carotid stenosis: definition and biological processes Hamostaseologie 23 2003 61 66
8. A. Kuehnl, J. Pelisek, and H.-H. Eckstein Das natriuretische Peptid Typ C wirkt anti-inflammatorisch auf humane Monozyten Gefäßchirurgie 15 2010 419
9. G.K. Hansson, and P. Libby The immune response in atherosclerosis: a double-edged sword Nat Rev Immunol 6 2006 508 519
10. J. Pelisek, A. Kuehnl, P.H. Rolland, C. Mekkaoui, A. Fuchs, and G.F. Walker Functional analysis of genomic DNA, cDNA, and nucleotide sequence of the mature C-type natriuretic peptide gene in vascular cells Arterioscler Thromb Vasc Biol 24 2004 1646 1651
11. V.H. Casco, J.P. Veinot, M.L. Kuroski de Bold, R.G. Masters, M.M. Stevenson, and A.J. de Bold Natriuretic peptide system gene expression in human coronary arteries J Histochem Cytochem 50 2002 799 809
12. J.N. Redgrave, P. Gallagher, J.K. Lovett, and P.M. Rothwell Critical cap thickness and rupture in symptomatic carotid plaques: the oxford plaque study Stroke 39 2008 1722 1729
13. H.C. Stary Natural history and histological classification of atherosclerotic lesions: an update Arterioscler Thromb Vasc Biol 20 2000 1177 1178
14. R. Virmani, A.P. Burke, A. Farb, and F.D. Kolodgie Pathology of the vulnerable plaque J Am Coll Cardiol 47 2006 C13 C18
15. K. Specht, T. Richter, U. Muller, A. Walch, M. Werner, and H. Hofler Quantitative gene expression analysis in microdissected archival formalin-fixed and paraffin-embedded tumor tissue Am J Pathol 158 2001 419 429
16. K. Inoue, K. Naruse, S. Yamagami, H. Mitani, N. Suzuki, and Y. Takei Four functionally distinct C-type natriuretic peptides found in fish reveal evolutionary history of the natriuretic peptide system Proc Natl Acad Sci U S A 100 2003 10079 10084
17. I. Pagel-Langenickel, J. Buttgereit, M. Bader, and T.H. Langenickel Natriuretic peptide receptor B signaling in the cardiovascular system: protection from cardiac hypertrophy J Mol Med 85 2007 797 810
18. M.B. Anand-Srivastava Natriuretic peptide receptor-C signaling and regulation Peptides 26 2005 1044 1059
19. J. Pelisek, A.T. Fuchs, A. Kuehnl, W. Tian, M.T. Kuhlmann, and P.H. Rolland C-type natriuretic peptide for reduction of restenosis: gene transfer is superior over single peptide administration J Gene Med 8 2006 835 844
20. A. Kühnl, J. Pelisek, W. Tian, M. Kuhlmann, P.H. Rolland, and C. Mekkaoui C-type natriuretic peptide inhibits constrictive remodeling without compromising re-endothelialization in balloon-dilated renal arteries J Endovasc Ther 12 2005 171 182
21. C.F. Bartels, H. Bukulmez, P. Padayatti, D.K. Rhee, C. van Ravenswaaij-Arts, and R.M. Pauli Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux Am J Hum Genet 75 2004 27 34
22. M. Piechota, M. Barylski, S. Hannam, D.P. Mikhailidis, J. Rysz, and M. Banach Natriuretic peptides in septic patients Curr Med Chem 16 2009 4020 4031
23. T. Walther, and H. Stepan C-type natriuretic peptide in reproduction, pregnancy and fetal development J Endocrinol 180 2004 17 22
24. S. Suga, H. Itoh, Y. Komatsu, Y. Ogawa, N. Hama, and T. Yoshimasa Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells - evidence for CNP as a novel autocrine/paracrine regulator from endothelial cells Endocrinology 133 1993 3038 3041
25. A.K. Kiemer, M.D. Lehner, T. Hartung, and A.M. Vollmar Inhibition of cyclooxygenase-2 by natriuretic peptides Endocrinology 143 2002 846 852
26. Vlachopoulos C, Ioakeimidis N, Terentes-Printzios D, Aznaouridis K, Baou K, Bratsas A, et al. Amino-terminal pro-C-type natriuretic peptide is associated with arterial stiffness, endothelial function and early atherosclerosis. Atherosclerosis.
27. S. Del Ry, C. Passino, M. Maltinti, M. Emdin, and D. Giannessi C-type natriuretic peptide plasma levels increase in patients with chronic heart failure as a function of clinical severity Eur J Heart Fail 7 2005 1145 1148
28. V. Gulberg, S. Moller, J.H. Henriksen, and A.L. Gerbes Increased renal production of C-type natriuretic peptide (CNP) in patients with cirrhosis and functional renal failure Gut 47 2000 852 857
29. A. Dietmann, P. Lackner, R. Helbok, K. Spora, S. Issifou, and B. Lell Opposed circulating plasma levels of endothelin-1 and C-type natriuretic peptide in children with Plasmodium falciparum malaria Malar J 7 2008 253
30. R. Yagci, Y. Totan, E. Ozluk, H. Ozyurt, G. Akbay, and M. Eksioglu Serum levels of natriuretic peptides in patients with Behcet's disease Clin Rheumatol 27 2008 1153 1158
31. K. Kimura, Y. Yamaguchi, M. Horii, H. Kawata, H. Yamamoto, and S. Uemura ANP is cleared much faster than BNP in patients with congestive heart failure Eur J Clin Pharmacol 63 2007 699 702
32. J. Mair Biochemistry of B-type natriuretic peptide-where are we now? Clin Chem Lab Med 46 2008 1507 1514